Cutia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2487 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 24BuyHK$49,920Lele ZhangIndividual5,200HK$9.60
08 Nov 24BuyHK$49,280Lele ZhangIndividual5,000HK$9.86
16 Oct 24BuyHK$59,660Lele ZhangIndividual5,000HK$11.93
15 Oct 24BuyHK$181,457Lele ZhangIndividual15,000HK$12.10
10 Oct 24BuyHK$89,968Lele ZhangIndividual7,000HK$12.85
09 Oct 24BuyHK$12,848Lele ZhangIndividual1,000HK$12.85
08 Oct 24BuyHK$421,697Yuqing HuangIndividual35,000HK$12.05
03 Oct 24BuyHK$287,880Yuqing HuangIndividual20,000HK$14.39
02 Oct 24BuyHK$459,804Yuqing HuangIndividual30,000HK$15.33
31 Jul 24SellHK$8,262,389Fidelity International LtdCompany1,094,400HK$7.55
26 Jun 24SellHK$463,281Yunfeng CapitalCompany80,600HK$5.75
28 May 24SellHK$13,964,803Fidelity International LtdCompany1,529,200HK$9.13
22 Mar 24SellHK$1,597,360Fidelity International LtdCompany187,400HK$8.52
07 Mar 24BuyHK$1,151,382Fidelity International LtdCompany165,800HK$6.94
05 Mar 24SellHK$27,830,397Fidelity International LtdCompany3,153,800HK$8.82

Insider Trading Volume

Insider Buying: 2487 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2487?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders12,592,7183.95%
Institutions16,420,5215.15%
General Public18,759,7575.89%
Employee Share Scheme54,019,02017%
VC/PE Firms216,795,96568%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.8%.


Top Shareholders

Top 11 shareholders own 94.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.6%
6 Dimensions Capital Limited
151,474,280HK$1.0b2.19%45.07%
17%
Cutia Therapeutics , ESOP
54,019,020HK$368.9m0%no data
12.4%
Yunfeng Capital
39,607,400HK$270.5m0%16.18%
8.07%
Sequoia Capital Operations LLC
25,714,285HK$175.6m0%0.13%
4.52%
Fidelity International Ltd
14,399,185HK$98.3m-17.4%0.01%
3.93%
Lele Zhang
12,507,718HK$85.4m0%no data
0.61%
Bosera Asset Management Co., Ltd.
1,949,600HK$13.3m0%0.01%
0.027%
Yuqing Huang
85,000HK$580.5k0%no data
0.021%
Huashang Fund Management Company Ltd.
67,400HK$460.4k0%no data
0.0013%
E Fund Management Co., Ltd.
4,136HK$28.3k0%no data
0.00006%
China Merchants Fund Management Company Ltd.
200HK$1.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cutia Therapeutics is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhuonan XuChina International Capital Corporation Limited
Hangci ZhengChina International Capital Corporation Limited
Yifan DuCitic Securities Co., Ltd.